National Path Lab

Hyperlipidemia

Hyperlipidemia refers to elevated levels of one or more blood lipids. Lipid testing is important for cardiovascular risk assessment and monitoring response to treatment.

A standard lipid profile provides the core information needed for most patients, while additional specialized markers (ApoB, Lp(a)) can provide further detail in selected individuals with specific risk profiles.

At National Path Lab (NPL), comprehensive lipid testing is available, from standard lipid profiles to specialized cardiovascular risk markers.

Tests available
4
Tests available
Health packages
2
Health packages

Tests Available at NPL

LIPOPROTEIN (A) ; LP (A)

Turn Around Time
SAMPLE DAILY BY 4:00 PM REPORT ON NEXT DAY EVENING

Rs. 2000

APOLIPOPROTEIN B (APO B)

Turn Around Time
SAMPLE DAILY BY 4:00 PM REPORT ON NEXT DAY EVENING

Rs. 1500

LIPID PROFILE

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 1000

LIPID PROFILE.

Turn Around Time
same day

Rs. 1000

About Hyperlipidemia

Causes & Risk Factors

Hyperlipidemia can result from genetic factors, lifestyle factors, or a combination of both:

•  Genetic (familial) hyperlipidemia — certain inherited conditions cause significantly elevated lipid levels from a young age.

•  Diet high in saturated fats and refined carbohydrates.

•  Obesity and sedentary lifestyle.

•  Diabetes and metabolic syndrome are commonly associated with abnormal lipid patterns.

•  Certain medical conditions (including hypothyroidism and kidney disease) and medications can also affect lipid levels.

Symptoms & When to Test

Hyperlipidemia is typically asymptomatic, which is why lipid screening (rather than symptom-based testing) is central to identifying and managing cardiovascular risk.

•  Usually asymptomatic — identified through screening rather than symptoms

•  In severe genetic forms, visible signs such as cholesterol deposits around the eyes or in tendons can occasionally occur

•  Often first identified in the context of a cardiovascular event, which underscores the value of proactive screening before this occurs

When Should You Consider Testing?

Testing is recommended for individuals with cardiovascular risk factors, diabetes or metabolic syndrome, hypertension, obesity, family history of premature cardiovascular disease, known cardiovascular disease, or those receiving lipid-lowering therapy requiring monitoring.

Why Tests Are Combined

A standard lipid profile (total cholesterol, LDL-C, HDL-C, triglycerides) provides the core information for most cardiovascular risk assessment, with non-HDL cholesterol calculated as an additional useful summary measure of atherogenic (artery-damaging) lipoprotein burden.

ApoB and Lipoprotein(a) [Lp(a)] are added in selected individuals because they can provide risk information beyond standard LDL-C alone — ApoB reflects the actual number of atherogenic particles (which can be discordant with LDL-C in some patients), while Lp(a) is a largely genetically determined risk factor not captured by standard lipid testing.

This tiered approach — standard panel for most patients, with specialized markers added for specific higher-risk or unclear situations — balances thoroughness with practicality, since not every patient needs the full range of specialized cardiovascular risk markers.

Tests Available at NPL

Test Code

Test

Clinical Relevance

B0045

 

Total Cholesterol

The overall measure of total cholesterol, bad, good cholesterol in blood. Another blood lipid relevant to cardiovascular and metabolic risk.

B0154

 

Apolipoprotein B (ApoB)

May provide additional information about the number of atherogenic lipoprotein particles.

B0155

 

Lipoprotein(a) [Lp(a)]

May be useful for assessing inherited cardiovascular risk in selected individuals.

Preparation requirements vary by specific test — please follow the instructions provided by your doctor or NPL for the tests ordered.

Home Sample Collection

NPL offers convenient home sample collection for Hyperlipidemia blood tests, so you don't need to visit a lab in person.

→ Book your test online, via the NPL app, or by calling +977 1 5970147 and select a convenient time slot for home sample collection.

→ A certified and experienced NPL phlebotomist visits your home at the scheduled time, following strict hygiene and safety protocols.

→ Your sample is transported under controlled, monitored conditions to NPL's ISO NABL ACCREDITED UNDER ISO15189:2022 laboratory for processing.

→ Your digital report is delivered securely to your phone or email, along with access to download and share it as needed.

When to See a Doctor

•  Known cardiovascular risk factors requiring lipid assessment

•  Diabetes or metabolic syndrome

•  Family history of premature cardiovascular disease

•  Known cardiovascular disease requiring lipid monitoring

•  Currently receiving lipid-lowering therapy — requires periodic monitoring

Medical Disclaimer

Laboratory tests support the evaluation of hyperlipidemia and cardiovascular risk but should not be interpreted in isolation. Reference ranges and clinical significance may vary according to the laboratory, patient characteristics, and clinical context. Final interpretation should be made by a qualified healthcare professional.

Related Packages

CARDIO CARE PACKAGE BASIC

Test Includes
10 Tests

Rs. 5500

CARDIO CARE PACKAGE ADVANCED

Test Includes
10 Tests

Rs. 6000

Frequently Asked Questions

Not always. Fasting requirements depend on the purpose of testing and your clinical situation — many guidelines now allow non-fasting lipid testing for general screening, though your doctor may request fasting in specific circumstances.
LDL-C measures the cholesterol content within LDL particles, while ApoB reflects the actual number of atherogenic particles (including LDL and other particles). In some patients, these can give different risk impressions, which is why ApoB is sometimes added for a more complete picture.
Not routinely for everyone — it is generally considered in selected individuals with a family history of premature cardiovascular disease or when standard risk assessment is unclear, since Lp(a) levels are largely genetically determined.
Yes, familial forms of hyperlipidemia exist and can cause significantly elevated lipid levels from a young age, which is why family history is an important part of cardiovascular risk assessment.
This depends on your specific treatment plan, as determined by your doctor, but periodic monitoring (often every few months initially, then less frequently once stable) is typical.